We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
964
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.33%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KYCH
2776
DELISTED
Keyarch Acquisition Corporation Ordinary Shares
KYCH
$483K ﹤0.01%
+49,000
New +$479K
LIAN
2777
DELISTED
LianBio American Depositary Shares
LIAN
$483K ﹤0.01%
223,391
+196,934
+744% +$669K
ETNB
2778
DELISTED
89bio
ETNB
$482K ﹤0.01%
+149,542
New +$451K
LITE icon
2779
Lumentum
LITE
$54.6B
$482K ﹤0.01%
6,064
-159,823
-96% -$13.7M
BODY.WS
2780
CALL
DELISTED
The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
BODY.WS
$481K ﹤0.01%
400,000
LIDRW icon
2781
CALL
AEye Inc Warrant
LIDRW
$282K
$478K ﹤0.01%
250,000
+37,176
+17% +$34.3K
ATIP.WS
2782
CALL
DELISTED
ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ATIP.WS
$478K ﹤0.01%
338,197
SG icon
2783
Sweetgreen
SG
$739M
$477K ﹤0.01%
+40,880
New +$862K
LTCHW
2784
CALL
DELISTED
Latch, Inc. Warrant expiring 6/4/2026
LTCHW
$475K ﹤0.01%
417,329
MLACW
2785
CALL
DELISTED
Malacca Straits Acquisition Company Limited Warrants
MLACW
$472K ﹤0.01%
46,411
LE icon
2786
Lands' End
LE
$372M
$471K ﹤0.01%
+44,379
New +$582K
ACET icon
2787
Adicet Bio
ACET
$75.4M
$470K ﹤0.01%
+2,012
New +$442K
NOTV
2788
DELISTED
Inotiv
NOTV
$468K ﹤0.01%
+48,727
New +$817K
PGTI
2789
DELISTED
PGT, Inc.
PGTI
$468K ﹤0.01%
+28,134
New +$506K
TLSIW icon
2790
CALL
TriSalus Life Sciences Warrant
TLSIW
$25.5M
$467K ﹤0.01%
47,455
GLS.WS
2791
CALL
DELISTED
Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
GLS.WS
$467K ﹤0.01%
301,304
ALIT icon
2792
Alight
ALIT
$547M
$466K ﹤0.01%
3,455
+2,760
+397% +$452K
HAIN icon
2793
Hain Celestial
HAIN
$46.4M
$464K ﹤0.01%
+19,559
New +$557K
PKE icon
2794
Park Aerospace
PKE
$773M
$463K ﹤0.01%
+36,272
New +$445K
PHAT icon
2795
Phathom Pharmaceuticals
PHAT
$949M
$462K ﹤0.01%
54,769
+30,417
+125% +$313K
PEARW
2796
CALL
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
$462K ﹤0.01%
300,000
-27,171
-8% -$13.4K
RVP icon
2797
Retractable Technologies
RVP
$20.5M
$461K ﹤0.01%
120,893
+31,272
+35% +$128K
ONC
2798
BeOne Medicines Ltd
ONC
$33.9B
$461K ﹤0.01%
2,842
-26,134
-90% -$4.08M
MBB icon
2799
iShares MBS ETF
MBB
$39.1B
$460K ﹤0.01%
4,712
-7,472
-61% -$733K
TUSK icon
2800
Mammoth Energy Services
TUSK
$131M
$460K ﹤0.01%
209,232
+166,737
+392% +$374K

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 964 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.